Montis’ mission is to therapeutically exploit cellular interactions between perivascular macrophages and tumor vasculature to drive and sustain immune reactions against solid tumors.
Employees: 1-10
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | Droia Onco... | droiaventu... |
| - | KU Leuven ... | lrd.kuleuv... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 14.06.2021 | Montis Biosciences Awarded VLAIO Grant to Expand its Pipelin... | Leuven, Belgium, 14 June 2021 -Montis Biosciences, a Belgium-based biotech company focused on the de... | alsaventur... |
| 31.03.2021 | Montis Biosciences appoints René Hoet as Chief Scientific Of... | Dr. Hoet brings 25 years of antibody research and development leadership to his new position as Mont... | alsaventur... |